SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eli Lilly Says Retatrutide Delivers Greater Weight Loss Than Ozempic

Eli Lilly said retatrutide delivered greater weight loss than Ozempic in adults with type 2 diabetes. The report also updates with Novo Nordisk's comments, but the available text is truncated.

LLYNVO
SquawkNews Desk

Related stories

Alamos Gold Posts Higher Q3 Adjusted Net Earnings YoY Alamos Gold reported higher adjusted net earnings year over year for the third quarter. M impact | EQUITY | Oct 29, 2026, 09:38 AM UTC 三六零 Says Q3 Revenue Fell 3.9% Year Over Year M impact | EQUITY | Oct 29, 2026, 09:38 AM UTC Linde Q3 Revenue Rises 9% on Higher Pricing and Volumes M impact | EQUITY | Oct 29, 2026, 09:38 AM UTC MGRC Reports Fiscal Q3 Profit and EPS MGRC reported fiscal 2026 third-quarter profit attributable to shareholders, up 2.84% year over year, and basic EPS. M impact | EQUITY | Oct 29, 2026, 09:37 AM UTC ROG Reports Fiscal Q3 Profit Growth of 161.3% ROG reported fiscal 2026 third-quarter profit attributable to shareholders up 161.3% year over year, with basic EPS also reported. M impact | EQUITY | Oct 29, 2026, 09:37 AM UTC PBI Reports Fiscal Q3 Profit and EPS Profit attributable to shareholders rose 36.94% year over year; basic EPS was also reported. M impact | EQUITY | Oct 29, 2026, 09:37 AM UTC